167 related articles for article (PubMed ID: 21512274)
1. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
Katano I; Ito R; Eto T; Aiso S; Ito M
Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
[TBL] [Abstract][Full Text] [Related]
2. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ
Yasuda M; Ogura T; Goto T; Yagoto M; Kamai Y; Shimomura C; Hayashimoto N; Kiyokawa Y; Shinohara H; Takahashi R; Kawai K
Exp Anim; 2017 Oct; 66(4):425-435. PubMed ID: 28679969
[TBL] [Abstract][Full Text] [Related]
3. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
4. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
[TBL] [Abstract][Full Text] [Related]
5. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
[TBL] [Abstract][Full Text] [Related]
6. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R
J Immunol; 2005 May; 174(10):6477-89. PubMed ID: 15879151
[TBL] [Abstract][Full Text] [Related]
7. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
8. Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg mice.
Seki T; Miyamoto A; Ohshima S; Ohno Y; Yasuda A; Tokuda Y; Ando K; Kametani Y
Biosci Trends; 2018 Jul; 12(3):247-256. PubMed ID: 29806632
[TBL] [Abstract][Full Text] [Related]
9. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
10. Lack of B cell leakiness in BALB/cA-nu, scid double mutant mice.
Hioki K; Kuramochi T; Endoh S; Terada E; Ueyama Y; Ito M
Exp Anim; 2001 Jan; 50(1):67-72. PubMed ID: 11326425
[TBL] [Abstract][Full Text] [Related]
11. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
12. NOD-Rag2null IL-2Rγnull mice: an alternative to NOG mice for generation of humanized mice.
Katano I; Ito R; Kamisako T; Eto T; Ogura T; Kawai K; Suemizu H; Takahashi T; Kawakami Y; Ito M
Exp Anim; 2014; 63(3):321-30. PubMed ID: 25077762
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2R gamma (null) mouse.
Kato C; Fujii E; Chen YJ; Endaya BB; Matsubara K; Suzuki M; Ohnishi Y; Tamaoki N
Lab Anim; 2009 Oct; 43(4):402-4. PubMed ID: 19505936
[TBL] [Abstract][Full Text] [Related]
14. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
[TBL] [Abstract][Full Text] [Related]
15. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
[TBL] [Abstract][Full Text] [Related]
16. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice.
Yahata T; Ando K; Nakamura Y; Ueyama Y; Shimamura K; Tamaoki N; Kato S; Hotta T
J Immunol; 2002 Jul; 169(1):204-9. PubMed ID: 12077246
[TBL] [Abstract][Full Text] [Related]
17. Data on long-term survival of the NOD/Shi-scid IL-2Rγ
Yamashita Y; Sato T; Noishiki K; Kobayashi K; Uchiyama A; Izumi H; Tamura T; Shikamura M; Oinishi Y; Saito M; Kawamata S
J Toxicol Sci; 2021; 46(10):453-469. PubMed ID: 34602530
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγ(null) mice generates humanized mice that improve functional B cell development.
Chung YS; Son JK; Choi B; Park JB; Chang J; Kim SJ
Clin Immunol; 2015 Dec; 161(2):308-15. PubMed ID: 26360254
[TBL] [Abstract][Full Text] [Related]
19. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
[TBL] [Abstract][Full Text] [Related]
20. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL
J Immunol; 2000 Mar; 164(5):2496-507. PubMed ID: 10679087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
